DPH001 (sorafenib formulation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DPH001 (sorafenib formulation), covering 2025-03-17 to 2025-03-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Pharmacokinetics of Sorafenib in Mesoporous Magnesium Carbonate (DPH001) Compared to Nexavar® (sorafenib) in Healthy Volunteers [EARLY_Phase 1]